4.6 Article

Pulmonary Ground-Glass Opacity (GGO) Lesions-Large Size and a History of Lung Cancer are Risk Factors for Growth

期刊

JOURNAL OF THORACIC ONCOLOGY
卷 3, 期 11, 页码 1245-1250

出版社

ELSEVIER SCIENCE INC
DOI: 10.1097/JTO.0b013e318189f526

关键词

Lung Adenocarcinoma; Ground-glass; Follow-up; Thin-section CT

资金

  1. Ministry of Education, Culture, Sports, Science and Technology
  2. Japan Society for the Promotion of Science
  3. Ministry of Health, Labour and Welfare
  4. Smoking Research Foundation
  5. Vehicle Racing Commemorative Foundation

向作者/读者索取更多资源

Objective: Ground-glass opacity (GGO) of the lung is being frequently detected by thin section computed tomography scan. However, the long term management of detected GGO is still unclear. To establish follow-up plans, we performed the clinical and radiological review to identify the factors that are closely associated with GGO growth. Methods: We retrospectively analyzed computed tomography images of 125 GGOs that were stable for 3 months between 1999 and 2006 at the Cancer Institute Hospital, Tokyo. To identify factors that affect the roentgenological growth, the time to GGO growth Curve by Kaplan-Meyer method was evaluated in terms of gender, age, smoking, initial size, existence of a solid part, GGO density, location, multiplicity, and lung cancer history by Univariate and multi-variate analyses. Results: The median observation period was 1048 days (177-3269) and 26 of 125 GGOs (21%) grew. The estimated growth Population for 5 years was 30%. The growth was more frequently seen in the elderly (p = 0.017), in part-solid GGO (p < 0.01) and in GGO of larger than 10 nm (p < 0.01, logrank test). By multivariate analysis, initial size (p < 0.01, Cox's model) and history of lung cancer (p = 0.017, logistic model) were independent factors that were significantly associated with GGO growth. Fifty GGOs that were 10 mm or smaller and without a lung cancer history did not grow within 3.5 years. Conclusions: After initial management and 3 month follow-up, larger size (more than 10 mm) and a history of lung cancer are risk factors for GGO growth, and therefore should be considered when making a follow-up plan.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据